Gender and clinical outcomes after starting highly active antiretroviral treatment: A cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue 2, 2002, Pages 197-202

  Moore, Antonia L ^a   Sabin, Caroline A ^a   Johnson, Margaret A ^a   Phillips, Andrew N ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Disease progression; Gender; HAART; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURVIVAL; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0036472054     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200202010-00015     Document Type: Article

References (24)

1. Changing patterns of mortality across Europe in patients infected with HIV - EuroSIDA Study Group
2. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss Cohort Study
3. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
4. Gender differences in virologic response to treatment in an HIV-positive population: A cohort study
5. Survival differences in patients with AIDS, 1979-89
6. Preliminary survival analysis of UK AIDS data
7. Sex differences in HIV-1 viral load and progression to AIDS
8. Do gender differences in CD4 cell counts matter?
9. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients
10. Race, sex drug use and progression of human immunodeficiency virus disease
11. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study
12. Sex differences in HIV-1 viral load and progression to AIDS
13. Association of race and gender with HIV-1
14. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 RNA disease in women
15. Admission to hospital in the HAART era. The EuroSIDA Study
16. Communicable Disease Report Weekly. AIDS and HIV in the United Kingdom: Monthly report
17. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men
18. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
19. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease
20. Disease progression and survival in HIV-1-infected Africans in London
21. Social determinants of health: Socioeconomic status, social class, and ethnicity
22. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative reanalysis. Collaborative Group on AIDS Incubation and HIV Survival, including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe
23. Survival after diagnosis of AIDS: A prospective observational study of 2625 patients